SSG Advises Navidea Biopharmaceuticals in the Sale of Substantially All Assets to Cardinal Health
SSG Capital Advisors served as the investment banker to Navidea Biopharmaceuticals in the sale of substantially all assets to Cardinal Health. The sale was effectuated through a Chapter 11 Section 363 process in the U.S. Bankruptcy Court for the District...
Read moreDetails









